For specialists

Possibilities of neuroprotection in the complex therapy of traumatic brain injury
Published in the journal “Emergency Medicine” № 7 (78) '2016
Omega-3 polyunsaturated fatty acids - the most important vector in maintaining the health of children and in the correction of autonomic disorders
Published in the journal «Modern Pediatrics» № 7(79)’2016
Pathogenetic and therapeutic aspects of using the drug Muscomed for vertebrogenic muscular-tonic syndromes
Published in a journal «International Neurological Journal» № 5 (83) ’2016
Prophylaxis of obstetric and perinatal complications in pregnant women after in vitro fertilization with thyroid pathology
Published in the journal «Women's Health» № 3 (109)’2016
Evaluation of the effectiveness of the combination of drugs Dorzamed and timolol 0.5% in the treatment of primary open-angle glaucoma
Published in a journal «Ophthalmological Journal» № 2’2016
Prophylaxis of obstetric and perinatal complications in pregnant groups of high perinatal risk using a vitamin-mineral complex
Collection of scientific works of the Association of Obstetricians and Gynecologists of Ukraine `2016
Clinical efficacy of an integrated approach in the treatment of refractive amblyopia with mixed astigmatism
VI Scientific and Practical Conference of Pediatric Ophthalmologists of Ukraine with International Participation '2015
Pharmacotherapy of depressive disorders in neurological practice: safety and efficacy problems
Published in the journal «Country of Doctors» May’2015
Depression: From Hippocrates to Modernity
Published in the journal «Modern Pharmacy» May’2015
Comparative study of the analgesic effect of Naproff and paracetamol in combination with chondroprotectors in the treatment of osteoarthritis
Published in the journal «The Practitioner» № 4’2015

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design